Autonomous Mobile Agents for Opioid Abuse Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Prescription Monitoring Program (PMP) systems are inefficient in identifying and predicting potential opioid abuse conditions, often requiring special formatting and being secured behind server-centric configurations that lead to excessive network load and latency, and are not optimally equipped for parallel processing, asynchronous execution, or fault-tolerance.
Innovation Solution
A computer system with a processor, memory, and communications interface configured to receive prescription drug monitoring program (PDMP) data, execute autonomous movable code, and utilize learning logic to predictively determine opioid abuse conditions, generating new code for transmission, thereby improving network efficiency and fault-tolerance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional server-centric PMP systems are used, then data security and centralized control are maintained, but network load increases and latency occurs
Solution Approach 1:
The patent segments the centralized PMP system into distributed mobile agents that can execute locally at point-of-care devices. Each agent contains specialized code for monitoring and analyzing prescription data, allowing parallel processing across multiple devices without requiring constant server communication. This segmentation reduces network latency while maintaining security through distributed validation.
Solution Approach 2:
The patent introduces mobile agents as intermediary components between the server and point-of-care devices. These agents cache and process data locally, acting as intermediaries that reduce direct server-client communication overhead. The agents maintain security protocols while enabling faster local decision-making about opioid abuse detection.
2Productivity
If conventional server-centric PMP systems are used, then centralized data processing is achieved, but parallel processing capability is limited
Solution Approach 1:
The patent divides the monolithic server-based processing architecture into multiple independent mobile agents that can execute in parallel on different devices. Each agent handles specific patient monitoring tasks independently, enabling simultaneous processing of multiple prescriptions and patient records without bottlenecking at a central server.
Solution Approach 2:
The patent implements dynamic agent creation and deployment, where mobile agents can be instantiated, activated, and deactivated based on real-time monitoring needs. This dynamic architecture allows the system to scale processing capacity flexibly, creating parallel processing threads only when and where needed, rather than maintaining a fixed complex infrastructure.
3Manufacturing precision
If conventional PMP systems with special formatting requirements are used, then data standardization is maintained, but system adaptability decreases
Solution Approach 1:
The patent employs parameter-based data handling where mobile agents can dynamically adjust data formatting requirements based on the specific context and data source. Rather than enforcing rigid formatting rules, the system uses configurable parameters that allow agents to adapt to different data formats while maintaining necessary validation standards for opioid abuse detection.
Solution Approach 2:
The patent creates universal mobile agents that can handle multiple data formats and sources through a common interface. These agents are designed to be format-agnostic, accepting various input types (prescription data, patient records, monitoring data) and processing them through standardized analytical routines, thereby maintaining adaptability while ensuring data quality through configurable validation parameters.
4Ease of operation
If conventional PMP systems are used, then basic monitoring functionality is provided, but predictive capability for opioid abuse is insufficient
Solution Approach 1:
The patent implements preliminary action by embedding predictive analytics code within the mobile agents themselves, rather than relying on post-hoc server analysis. The agents continuously evaluate risk factors and predict potential opioid abuse conditions in real-time as data is collected, enabling early intervention before abuse patterns fully develop. This preliminary prediction capability is integrated into the basic monitoring function.
Solution Approach 2:
The patent incorporates feedback loops where mobile agents continuously monitor prescription patterns, compare them against known abuse indicators, and adjust their predictive models in real-time. The system provides feedback to both the agents (for model refinement) and to healthcare providers (for clinical decision-making), thereby enhancing prediction accuracy while maintaining ease of operation through automated analysis.
Data Source
AI summary
Technologies and techniques for processing drug data in a specialized medical computer system. Autonomous moving code may be received via a communications interface from a computer network, where the autonomous movable code includes patient data, lab test data, demographic data, and diagnosis data. The autonomous movable code is executed in a system agent manager and processed in a learning module, where the learning module performs predictive processing to determine if an opioid abuse condition exists. New autonomous movable code may be generated that includes information and/or instructions regarding the opioid abuse condition. The new autonomous movable code is then transmitted back to the computer network.